skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: miR-129 suppresses tumor cell growth and invasion by targeting PAK5 in hepatocellular carcinoma

Abstract

Emerging evidence suggests that microRNAs (miRNAs) play important roles in regulating HCC development and progression; however, the mechanisms by which their specific functions and mechanisms remained to be further explored. miR-129 has been reported in gastric cancers, lung cancer and colon cancer. In this study, we disclosed a new tumor suppresser function of miR-129 in HCC. We also found the downregulation of miR-129 occurred in nearly 3/4 of the tumors examined (56/76) compared with adjacent nontumorous tissues, which was more importantly, correlated to the advanced stage and vascular invasion. We then demonstrated that miR-129 overexpression attenuated HCC cells proliferation and invasion, inducing apoptosis in vitro. Moreover, we used miR-129 antagonist and found that anti-miR-129 promoted HCC cells malignant phenotypes. Mechanistically, our further investigations revealed that miR-129 suppressed cell proliferation and invasion by targeting the 3’-untranslated region of PAK5, as well as miR-129 silencing up-regulated PAK5 expression. Moreover, miR-129 expression was inversely correlated with PAK5 expression in 76 cases of HCC samples. RNA interference of PAK5 attenuated anti-miR-129 mediated cell proliferation and invasion in HCC cells. Taken together, these results demonstrated that miR-129 suppressed tumorigenesis and progression by directly targeting PAK5, defining miR-129 as a potential treatment target for HCC. - Highlights:more » • Decreased of miR-129 is found in HCC and associated with advanced stage and metastasis. • miR-129 suppresses proliferation and invasion of HCC cells. • miR-129 directly targets the 3′ UTR of PAK5 and diminishes PAK5 expression. • PAK5 is involved in miR-129 mediated suppression functions.« less

Authors:
 [1];  [2]; ; ;  [1];  [1];  [2]
  1. Department II of Interventional Radiology, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438 (China)
  2. Department II of Special Medical Care, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438 (China)
Publication Date:
OSTI Identifier:
22462181
Resource Type:
Journal Article
Journal Name:
Biochemical and Biophysical Research Communications
Additional Journal Information:
Journal Volume: 464; Journal Issue: 1; Other Information: Copyright (c) 2015 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.; Country of input: International Atomic Energy Agency (IAEA); Journal ID: ISSN 0006-291X
Country of Publication:
United States
Language:
English
Subject:
60 APPLIED LIFE SCIENCES; ANIMAL TISSUES; APOPTOSIS; CELL PROLIFERATION; HEPATOMAS; IN VITRO; INHIBITION; LARGE INTESTINE; LUNGS; METASTASES; PHENOTYPE; PLANT GROWTH; RNA; TUMOR CELLS

Citation Formats

Zhai, Jian, Qu, Shuping, Li, Xiaowei, Zhong, Jiaming, Chen, Xiaoxia, Qu, Zengqiang, and Wu, Dong. miR-129 suppresses tumor cell growth and invasion by targeting PAK5 in hepatocellular carcinoma. United States: N. p., 2015. Web. doi:10.1016/J.BBRC.2015.06.108.
Zhai, Jian, Qu, Shuping, Li, Xiaowei, Zhong, Jiaming, Chen, Xiaoxia, Qu, Zengqiang, & Wu, Dong. miR-129 suppresses tumor cell growth and invasion by targeting PAK5 in hepatocellular carcinoma. United States. https://doi.org/10.1016/J.BBRC.2015.06.108
Zhai, Jian, Qu, Shuping, Li, Xiaowei, Zhong, Jiaming, Chen, Xiaoxia, Qu, Zengqiang, and Wu, Dong. 2015. "miR-129 suppresses tumor cell growth and invasion by targeting PAK5 in hepatocellular carcinoma". United States. https://doi.org/10.1016/J.BBRC.2015.06.108.
@article{osti_22462181,
title = {miR-129 suppresses tumor cell growth and invasion by targeting PAK5 in hepatocellular carcinoma},
author = {Zhai, Jian and Qu, Shuping and Li, Xiaowei and Zhong, Jiaming and Chen, Xiaoxia and Qu, Zengqiang and Wu, Dong},
abstractNote = {Emerging evidence suggests that microRNAs (miRNAs) play important roles in regulating HCC development and progression; however, the mechanisms by which their specific functions and mechanisms remained to be further explored. miR-129 has been reported in gastric cancers, lung cancer and colon cancer. In this study, we disclosed a new tumor suppresser function of miR-129 in HCC. We also found the downregulation of miR-129 occurred in nearly 3/4 of the tumors examined (56/76) compared with adjacent nontumorous tissues, which was more importantly, correlated to the advanced stage and vascular invasion. We then demonstrated that miR-129 overexpression attenuated HCC cells proliferation and invasion, inducing apoptosis in vitro. Moreover, we used miR-129 antagonist and found that anti-miR-129 promoted HCC cells malignant phenotypes. Mechanistically, our further investigations revealed that miR-129 suppressed cell proliferation and invasion by targeting the 3’-untranslated region of PAK5, as well as miR-129 silencing up-regulated PAK5 expression. Moreover, miR-129 expression was inversely correlated with PAK5 expression in 76 cases of HCC samples. RNA interference of PAK5 attenuated anti-miR-129 mediated cell proliferation and invasion in HCC cells. Taken together, these results demonstrated that miR-129 suppressed tumorigenesis and progression by directly targeting PAK5, defining miR-129 as a potential treatment target for HCC. - Highlights: • Decreased of miR-129 is found in HCC and associated with advanced stage and metastasis. • miR-129 suppresses proliferation and invasion of HCC cells. • miR-129 directly targets the 3′ UTR of PAK5 and diminishes PAK5 expression. • PAK5 is involved in miR-129 mediated suppression functions.},
doi = {10.1016/J.BBRC.2015.06.108},
url = {https://www.osti.gov/biblio/22462181}, journal = {Biochemical and Biophysical Research Communications},
issn = {0006-291X},
number = 1,
volume = 464,
place = {United States},
year = {Fri Aug 14 00:00:00 EDT 2015},
month = {Fri Aug 14 00:00:00 EDT 2015}
}